Omahan Donated $3 million for prostate cancer research to Buffett Cancer Center
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
On Dec. 6, 2017, Costco Founder Jeffrey and Susan Brotman and Pam and Dan Baty announced a $50…
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Nov. 29, 2017, scientists at The Scripps Research Institute (TSRI) announced they had designed a bacterium with…
On Nov. 28, 2017, surgeons at University of Washinton Medicine in Seattle announced they had performed the first…
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
On. Nov. 13, 2017, research by Dr. Patrick McGovern, Director of the Biomolecular Archaeology Laboratory at the University…
On Nov. 10, 2017, the Wyss Medical Foundation pledged $2 million to support James P. Stannard as the…
On Nov. 9, 2017, UNMC announced that Jingwei Xie, Ph.D, a biomedical engineer, had been awarded a four-year,…
On Nov. 9, 2017, the FDA licensed Heplisav-B, the new hepatitis B vaccine, to Berkeley-based Dynavax Technologies for…
On Nov. 3, 2017, construction started on the Calgary Cancer Centre located at the northeast corner of the…
On Dec. 1, 2017, Quest Diagnostics announced it acquired Cleveland HeartLab, a leader in innovative diagnostic services for…
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
On Oct. 23, 2017, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Shingrix (Zoster Vaccine…
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
On Oct. 17, 2017, Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer…
On Oct. 12, 2017, the NIH and 11 leading biopharmaceutical companies launched the Partnership for Accelerating Cancer Therapies…
On Oct. 11, 2017, researchers funded by the National Institutes of Health (NIH) announced they had completed a…
On Oct. 11, 2017, the Paul G. Allen Frontiers Group announced the creation of two new Allen Discovery…
On Oct. 6, 2017, UC Berkeley researchers announced they had developed reimagined fMRI techniques and instruments to boost…
On Oct. 2, 2017, Emory University’s Center for Selective C-H Functionalization (CCHF) was awarded a $20 million grant…
On Oct. 2, 2017, Emory University was selected by the National Cancer Institute (NCI) for participation in an…
On Oct. 2, 2017, The Nobel Assembly announced that Michael Rosbash, a HHMI investigator, Jeffrey Hall of Brandeis…
On Sept. 20, 2017, resarchers at deCODE genetics use whole-genome data from 14,000 people from across the population…
On Sept. 18, 2017, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
On Sept. 15, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated GamaSTAN S/D prescribing…
On Sept. 6, 2017, PATH announced it has received a $120 million grant from the Bill & Melinda…
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…